Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Short-term Investments (2017 - 2024)

Solid Biosciences' Short-term Investments history spans 8 years, with the latest figure at $106.7 million for Q3 2024.

  • For Q3 2024, Short-term Investments rose 13.72% year-over-year to $106.7 million; the TTM value through Sep 2024 reached $106.7 million, up 13.72%, while the annual FY2023 figure was $49.6 million, 14.94% down from the prior year.
  • Short-term Investments for Q3 2024 was $106.7 million at Solid Biosciences, up from $94.4 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $108.6 million in Q2 2022 and bottomed at $90000.0 in Q2 2021.
  • The 5-year median for Short-term Investments is $68.6 million (2023), against an average of $61.5 million.
  • The largest annual shift saw Short-term Investments plummeted 99.02% in 2020 before it surged 120535.56% in 2022.
  • A 5-year view of Short-term Investments shows it stood at $400000.0 in 2020, then skyrocketed by 22060.75% to $88.6 million in 2021, then crashed by 34.19% to $58.3 million in 2022, then decreased by 14.94% to $49.6 million in 2023, then soared by 115.06% to $106.7 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Short-term Investments are $106.7 million (Q3 2024), $94.4 million (Q2 2024), and $88.5 million (Q1 2024).